Nations's First-of-its-Kind Endometriosis Scientific Workshop Aims to Improve the Quality of Life for Malaysian Women

Thomson Fertility (also known as TMC Fertility) together with Thomson Hospital Kota Damansara and Monash University Australia collaborate to bring together endometriosis experts from United Kingdom and Australia.
PETALING JAYA, MALAYSIA - Media OutReach Newswire - 4 June 2025 - Thomson Fertility (also known as TMC Fertility) marked a significant milestone in women's healthcare by hosting the Holistic Endometriosis Care Scientific Workshop at Thomson Hospital Kota Damansara. The event brought together international experts from the University of Oxford's Endometriosis CaRe Centre, Monash University (Malaysia & Australia), and University of Warwick to address the complex management of endometriosis – a condition affecting 1 in 10 Malaysian women.
Themed "Holistic Endometriosis Care – From Bench to Bedside", the workshop was designed to elevate awareness, diagnostics, and multidisciplinary care beginning at the primary healthcare level, while reinforcing the link between endometriosis and infertility.
In her opening remarks, Ms Lakshmi Menon, CEO of Thomson Fertility (also known as TMC Fertility), shared the team's long-term commitment to raising the standard of care in women's health and fertility:
"We are proud to lead conversations that matter. This workshop underscores our role not just as a fertility centre, but as a regional leader in holistic women's healthcare. Empowering primary care providers is key to ensuring women get the right diagnosis early—especially when endometriosis is so closely linked with fertility struggles. Together with our international partners, we aim to transform the future of women's care in Malaysia."
Driving Early Diagnosis, Multidisciplinary Management and Fertility Education
The workshop featured cutting-edge research and practical approaches to improve diagnosis, pain management, and long-term care for women with endometriosis. Among the key topics discussed:
Proven practices from Oxford's Endometriosis CaRe Centre that have improved patient outcomes in the UK.
The importance of early diagnosis and the role of primary care in managing chronic pelvic pain.
Updates on the European Society of Human Reproduction and Embryology (ESHRE) guidelines on endometriosis treatment.
Fertility preservation strategies and the impact of untreated endometriosis on reproductive health.
Expert Perspectives on a Global Health Challenge
Prof. Dr. Prasanna Supramaniam, Consultant Obstetrician and Gynaecologist at Thomson Fertility (also known as TMC Fertility) and Honorary Senior Clinical Lecturer, University of Oxford, stated:
"This is the first workshop of its kind in Malaysia, and it's time we addressed the reality that many women suffer in silence. Pain is not normal, and primary care doctors are our first line of defence. This initiative is part of our long-standing commitment to endometriosis education, awareness, and fertility support."
Prof. Christian Becker, Lead of the Oxford BSGE Endometriosis Centre and Co-Director of the Oxford Endometriosis CaRe Centre, added:
"Endometriosis remains underdiagnosed globally. I'm honoured to share our research and see Thomson Fertility take a leadership role in improving care pathways in this region."
Globally, endometriosis remains one of the most underdiagnosed chronic conditions, affecting millions of women—often without their knowledge. According to the Ministry of Health Malaysia, approximately 1 in 10 Malaysian women are believed to suffer from endometriosis, yet many remain unaware of their condition due to delayed diagnosis and lack of awareness.
The disease characterised by tissue similar to the uterine lining growing outside the uterus can cause debilitating pain, especially during menstruation, sexual intercourse, urination, or defecation. If left untreated, it can significantly affect fertility and quality of life.
Adding a local perspective, Prof. J. Ravichandran, Senior Consultant Obstetrician & Gynaecologist and Maternal Foetal Medicine Consultant at Hospital Sultanah Aminah, Johor Bahru, shared:
"Endometriosis is an enigmatic disease. Many women live through cycles of pain, ineffective medication, and repeat surgeries due to delayed or inadequate treatment. There is an urgent need for better data and early intervention strategies to optimise care."
Monthly Endometriosis Day Initiative by Thomson Fertility
As part of its ongoing mission to reshape women's healthcare in Malaysia, Thomson Fertility (also known as TMC Fertility) has launched Endo Care @ Thomson—a monthly awareness initiative held on the first Saturday of every month.
Each session offers educational talks and workshops by fertility and gynaecology experts.
This monthly programme is open to the public and aims to break the silence around menstrual health and endometriosis, helping women seek the care they need without hesitation.
REFERENCES
The workshop featured a distinguished panel of medical professionals, each contributing valuable expertise on endometriosis management:
Prof. Dr. Prasanna Supramaniam – Associate Professor, Consultant Obstetrician and Gynaecologist, TMC Fertility @Thomson Hospital, Subspecialist in Reproductive Medicine and Surgery, Minimally Invasive Gynaecological Surgeon, Honorary Senior Clinical Lecturer, University of Oxford
Prof. Krina Zondervan – Head of Department, Professor of Reproductive & Genomic Epidemiology, Co-Director Endometriosis CaRe Centre, University of Oxford
Prof. Christian Becker – Professor of Reproductive Science, Consultant Gynaecologist Subspecialist in Reproductive Medicine, Lead for Oxford BSGE Endometriosis Centre, Co-Director Oxford Endometriosis CaRe Centre, University of Oxford
Prof. Katy Vincent – Senior Fellow in Pain in Women, Professor in Gynaecological Pain Principal Investigator, Research Group Leader, Honorary Consultant Gynaecologist, University of Oxford
Dr. Thomas Tapmeier – Head, Uterine Biology & Gynaecological Disease Group, Department of Obstetrics & Gynaecology, Monash University, Visiting Fellow, Nuffield Department of Women's & Reproductive Health, University of Oxford
Dr. Kurtis Garbutt – Data Scientist, Endometriosis CaRe Centre, University of Oxford
Prof. Beverley Vollenhoven Am – Carl Wood Chair, Obstetrics and Gynaecology, Monash University, Director of Gynaecology and Research, Women's and Newborn Program, Monash Health, Monash University
Prof. J. Ravichandran – Professor of O&G, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Senior Consultant Obstetrician, Gynaecologist and Maternal Foetal Medicine Consultant, Hospital Sultanah Aminah, Johor Bahru
Dr. Hannah Nazri – NIHR Academic Clinical Fellow in Obstetrics & Gynaecology, University of Warwick, Early Career Ambassador of World Endometriosis Society, International Relations Research Subcommittee Member of BSGE, President of Boston Congress of Public Health
Hashtag: #ThomsonFertility
The issuer is solely responsible for the content of this announcement.
ABOUT THOMSON FERTILITY
Established in 1994, Thomson Fertility (also known as TMC Fertility) is Malaysia's leading fertility centre known for its exceptional care and high success rates. With multiple branches across Peninsular Malaysia, it offers advanced fertility treatments supported by state-of-the-art laboratories and quality medications. With over 30 years of experience and state-of-the-art facilities, Thomson Fertility is committed to helping individuals and couples achieve their dream of parenthood.
Thomson Fertility

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

UAE Moments

11 minutes ago

• UAE Moments

Your Daily Tagalog Horoscope: Lunes, June 23, 2025

Be patient today, lalo na sa trabaho. Hindi mo kailangan patunayan ang lahat. Read More: Can Your Mindset Lead to More Positive Life Outcomes? Read More: Which Arab Dish Are You, According to Your Zodiac Sign Read More: The Best Places to Travel Based on Your Zodiac Sign Taurus May darating na chismis, pero huwag agad maniwala. I-check mo muna. Gemini Creative energy is high. Gamitin sa passion o content creation. Click here to follow our WhatsApp channel for tarot readings, love, health, career, and Chinese horoscopes delivered to your phone daily! Cancer Emotional ka pa rin, pero may taong handang makinig. Huwag itago ang nararamdaman. Leo Gusto mong magpahinga pero ang daming kailangan gawin. Prioritize mo lang. Read More: The Best Careers for Each Zodiac Sign Virgo May sense of clarity ka today. Parang may switch na biglang nag-on. Libra Social battery low. Ok lang mag-cancel plans kung hindi ka na kaya. Scorpio Pwedeng may unexpected expense. Check your wallet bago gumastos. Read More: Comfort Food You Should Eat According to Your Zodiac Sign Sagittarius You're craving something new. Pwedeng food, pwedeng experience—go lang! Capricorn Maging proud sa sarili kahit simpleng progress lang. Progress is progress. Aquarius May good convo na darating. Pwedeng magbago ng pananaw mo sa isang issue. Pisces Baka ma-overwhelm ka sa dami ng gusto mong gawin. Isa-isa lang, fishy. A Guide to All 12 Astrological Signs Get your hor oscope reading to your inbox by 6 a.m. every morning! Sign up here. Join our FREE WhatsApp news channel and stay up to date about events happening in the GCC. Subscribe to our Telegram channel here.

Zawya

14 hours ago

• Zawya

Key Findings from the "Hong Kong Vitiligo Patients and Caregivers Survey" Released for "World Vitiligo Day"

Patients Demonstrate Significant Knowledge Gaps in Treatment Options, Leading to Lost Hope and Treatment Discontinuation Over 70% of Vitiligo Patients Desire Skin Repigmentation; New Topical Therapy Introduced in Hong Kong Shows Encouraging Results HONG KONG SAR - Media OutReach Newswire - 22 June 2025 - In observance of World Vitiligo Day (June 25), Hong Kong Vitiligo Support Group has released findings from its latest "Hong Kong Vitiligo Patients and Caregivers Survey." The study reveals critical gaps in treatment knowledge, with over 80% of respondents demonstrating limited understanding of available therapies and their efficacy. More than 70% of patients hoped therapy could partially or fully restore their original skin pigmentation, yet many reported disappointing outcomes with existing treatments, leading to loss of confidence and treatment discontinuation. Dr. Chan Yung, a specialist in dermatology, noted that with advancing insights into vitiligo pathogenesis, novel therapy has recently been introduced in Hong Kong. Clinical studies confirm its repigmentation potential, encouraging patients to consult specialists for personalized treatment plans. In Hong Kong, vitiligo affects approximately 1% of the population, with an estimated 70,000 individuals living with the condition. In May 2025, Hong Kong Vitiligo Support Group successfully surveyed 61 patients or their primary caregivers to identify key challenges in disease management. Key findings as follows: 1. Critical Knowledge Deficits in Treatment Understanding 80% lack understanding of treatment options 78% unfamiliar with medication efficacy 84% uncertain about which specialist to consult 2. Disparity Between Treatment Expectations and Outcomes 74% of respondents expressed a desire for full or partial skin repigmentation, yet among the 48 treated patients, none achieved complete repigmentation, and only 8% reported partial improvement 67% perceived treatments as completely ineffective 3. Treatment Discontinuation Due to Lost Confidence 43% are not receiving any active treatment at present Barriers included: high private healthcare costs and long public-sector wait times (95%), and perceived futility of therapy (75%) Vitiligo is classified as segmental (SV) or non-segmental (NSV), with 90% of cases being NSV—a subtype with higher progression risk and greater therapeutic difficulty. Traditional options (e.g., topical corticosteroids, topical calcineurin inhibitors, phototherapy) often yield variable results, with limitations such as: Corticosteroids: Risk of skin atrophy, telangiectasia; unsuitable for long-term use Phototherapy: Requires 3–6 months (or longer) of 2–3 weekly sessions, with potential sunburn and skin cancer risks Non-steroidal topicals: Often only slow progression rather than induce repigmentation Over 70% of Vitiligo Patients Seek Skin Repigmentation - New Topical Treatment Introduced in Hong Kong Offers Hope Dr. Chan Yung stated that targeted therapies like topical JAK inhibitors represent a breakthrough in vitiligo treatment. "Topical JAK inhibitors are non-steroidal medications with demonstrated efficacy and safety profiles, making them a viable long-term treatment option for patients," he explained. While the exact etiology of vitiligo remains unclear, current evidence suggests autoimmune-mediated attack on melanocytes plays a key pathogenic role, resulting in depigmented lesions. Non-steroidal Topical JAK inhibitors work by modulating the aberrant immune signaling responsible for melanocyte attack, enabling gradual repigmentation of affected areas. Ruxolitinib cream, the first FDA-approved non-steroidal topical JAK inhibitor for localized treatment of non-segmental vitiligo in patients aged 12 years and above, has recently become available in Hong Kong. Clinical trials show: Approximately 30% of patients achieved ≥75% improvement in Facial Vitiligo Area Scoring Index (F-VASI) after 24 weeks of treatment; 50% of patients showed ≥50% improvement; Extension to 52 weeks of treatment resulted in >50% of patients attaining ≥75% improvement 7 Ms. Amy Wong, a Registered Social Worker at Hong Kong Vitiligo Support Group noted that many vitiligo patients and caregivers seeking assistance express confusion about treatment options and medication efficacy. "Many patients spend over a year just obtaining a definitive diagnosis," she explained. "In their search for solutions, patients often invest substantial resources in various cosmetic packages and alternative therapies, only to experience significant discrepancies between desired and actual outcomes. This frequently leads to disillusionment, loss of hope for effective treatment, and even emotional distress." "However," Ms. Wong emphasized, "with medical advancements, vitiligo is no longer considered untreatable. Repigmentation is now achievable, and we strongly encourage patients to seek professional medical consultation at the earliest opportunity." Conclusion and Recommendations The survey reveals significant gaps in patients' understanding of vitiligo treatments and their mechanisms, leaving many uncertain about where to begin treatment. Over 80% of respondents expressed desire for patient support in medication access and resource referrals. Accordingly, Dr. Chan Yung and Ms. Amy Wong, propose the following recommendations: 1. Public Education Seminars Conduct lectures and workshops to help patients and caregivers understand that vitiligo requires long-term management, with visible results often taking extended periods to manifest. These initiatives should also educate participants about various treatment modalities, particularly newly available options like non-steroidal topical JAK inhibitors, enabling informed discussions with healthcare providers about appropriate treatment plans. 2. Medication Support and Resource Referral Services Given that vitiligo necessitates prolonged treatment, and considering that many patients find private care cost-prohibitive while public service wait times are excessively long, we recommend establishing medication support and resource referral services to facilitate timely access to proper treatment. Hong Kong Vitiligo Support Group is currently implementing a "Vitiligo Patient Support Program," offering free psychological counseling, medication assistance, and resource referral services. Interested individuals may contact Hong Kong Vitiligo Support Group for details. Case Study Mr. Chan (pseudonym), 58, first developed symptoms thirty years ago with a small depigmented spot on his neck that subsequently spread to his neck, waist, wrists, and thighs. At diagnosis, his physician prescribed topical corticosteroids but stated vitiligo was essentially "incurable." Mr. Chan subsequently pursued numerous alternative treatments including UV light therapy, traditional Chinese medicine, electroacupuncture, topical shampoo applications, and cosmetic packages - exhausting savings and liquidating his stocks - all without achieving satisfactory repigmentation. After years of unsuccessful treatment attempts, he discontinued treatment until being referred to the Hong Kong Vitiligo Support Group. Through their seminars and "Vitiligo Patient Support Program", he learned about modern treatment advances and, with medication assistance, has begun new therapy with renewed hope for repigmentation. "My greatest wish is to wear crew-neck shirts again," Mr. Chan shared. "Since developing vitiligo, I've only worn high-collared shirts to conceal neck patches and haven't gone swimming in thirty years." He looks forward to regaining sartorial freedom following successful repigmentation. Hashtag: #Vitiligo #WorldVitiligoDay #TopicalJAKinhibitors #Non-steroidalTopicalJAKinhibitors #Ruxolitinibcream #SkinRepigmentation # #Dermatology #Skincare#HongKongVitiligoSupportGroup The issuer is solely responsible for the content of this announcement. About Hong Kong Vitiligo Support Group Initiated by social enterprise Hong Kong Health Care Alliance, Hong Kong Vitiligo Support Group is a non-profit patient organization dedicated to individuals affected by vitiligo and their caregivers. Our mission is to enhance societal understanding of vitiligo through comprehensive disease education and support services, empowering patients to better understand and confront their condition while fostering public awareness. We strive to ensure no patient faces this journey alone. Hong Kong Vitiligo Support Group

UAE Moments

a day ago

• UAE Moments

Your Daily Tagalog Horoscope: Linggo, June 22, 2025

Mas productive ka ngayong araw. Sulitin ito para matapos ang mga na-pending. Read More: Can Your Mindset Lead to More Positive Life Outcomes? Read More: Which Arab Dish Are You, According to Your Zodiac Sign Read More: The Best Places to Travel Based on Your Zodiac Sign Taurus May good vibes kang madadala sa iba. Isang smile mo lang, game changer na. Gemini Huwag mong i-overthink ang simpleng bagay. Chill lang. Click here to follow our WhatsApp channel for tarot readings, love, health, career, and Chinese horoscopes delivered to your phone daily! Cancer May taong nagpaparamdam pero hindi klaro ang intentions. Baka mixed signals lang. Leo Panahon na para i-push ang goals mo. Walang mangyayari kung puro drawing lang. Read More: The Best Careers for Each Zodiac Sign Virgo May unexpected blessing ka today. Pasalamat ka kahit maliit. Libra Matutong magsabi ng "hindi" kung kailangan. Boundaries, bes! Scorpio Baka mahuli mo ang isang sikreto. Huwag mong ikalat agad. Read More: Comfort Food You Should Eat According to Your Zodiac Sign Sagittarius Adventure vibes! Kahit short trip, go lang kung may chance. Capricorn Isang project ang kailangang tapusin ngayon. Time to hustle! Aquarius Maging honest sa sarili kung saan ka masaya. Walang masama kung magbago ng isip. Pisces Nakaka-miss ang pamilya. Isang tawag lang, baka mapawi ang lungkot. A Guide to All 12 Astrological Signs Get your hor oscope reading to your inbox by 6 a.m. every morning! Sign up here. Join our FREE WhatsApp news channel and stay up to date about events happening in the GCC. Subscribe to our Telegram channel here.